[{"Assets_0_Q3_USD":613816000.0,"CommonStockSharesOutstanding_0_Q3_shares":42958401.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-53722000.0,"NetIncomeLoss_1_Q3_USD":-36490000.0,"NetIncomeLoss_3_Q3_USD":-116168000.0,"StockholdersEquity_0_Q3_USD":245957000.0,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191030"}]